Sentinel lymph node biopsy for prostate cancer: A hybrid approach

Journal of Nuclear Medicine

Volumn 54, Issue 4, 2013, Pages 493-496

  Van Den Berg, Nynke S ^a   Valdés Olmos, Renato A ^a,b   Van Der Poel, Henk G ^b   Van Leeuwen, Fijs W B ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Image guided surgery; Interventional molecular imaging; Multimodal; Prostate cancer; Sentinel lymph node

Indexed keywords

IODINE 125; NANOCOLLOID TC 99M; TRACER; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INTRAOPERATIVE PERIOD; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIOSURGERY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TRANSRECTAL ULTRASONOGRAPHY; VALIDITY;

HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS; INTRAOPERATIVE PERIOD; MALE; PROSTATIC NEOPLASMS; RADIOACTIVE TRACERS; SENTINEL LYMPH NODE BIOPSY;

EID: 84875799883     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.113746     Document Type: Article

References (25)

1. Holl G, Dorn R, Wengenmair H, Weckermann D, Sciuk J. Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2, 000 patients. Eur J Nucl Med Mol Imaging. 2009;36:1377-1382.
2. Joniau S, Van den Bergh L, Lerut E, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. 2013;63:450-458.
3. Mattei A, Fuechsel FG, Bhatta Dhar N, et al. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol. 2008;53:118-125.
4. Meinhardt W, van der Poel HG, Valdes Olmos RA, Bex A, Brouwer OR, Horenblas S. Laparoscopic sentinel lymph node biopsy for prostate cancer: the relevance of locations outside the extended dissection area. Prostate Cancer. 2012;2012:751753.
5. van den Berg NS, van Leeuwen FW, van der Poel HG. Fluorescence guidance in urologic surgery. Curr Opin Urol. 2012;22:109-120.
6. Uren RF. Lymphatic drainage of the skin. Ann Surg Oncol. 2004;11(suppl): 179S-185S.
7. 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med. 2012;53:1034-1040.
8. Buckle T, Chin PT, van Leeuwen FW. (Non-targeted) radioactive/fluorescent nanoparticles and their potential in combined pre- and intraoperative imaging during sentinel lymph node resection. Nanotechnology. 2010;21:482001.
9. Emerson DK, Limmer KK, Hall DJ, et al. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. Radiology. 2012;265:186-193.
10. 18F-FDG. J Nucl Med. 2012;53:1438-1445.
11. Kuil J, Velders AH, van Leeuwen FW. Multimodal tumor-targeting peptides functionalized with both a radio- and a fluorescent label. Bioconjug Chem. 2010;21:1709-1719.
12. Azhdarinia A, Ghosh P, Ghosh S, Wilganowski N, Sevick-Muraca EM. Duallabeling strategies for nuclear and fluorescence molecular imaging: a review and analysis. Mol Imaging Biol. 2012;14:261-276.
13. Banerjee SR, Pullambhatla M, Byun Y, et al. Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen. Angew Chem Int Ed Engl. 2011;50:9167-9170.
14. Buckle T, Brouwer OR, Valdes Olmos RA, van der Poel HG, van Leeuwen FW. Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients. J Nucl Med. 2012;53:1026-1033.
15. Fütterer JJ, Barentsz JO. MR imaging-guided and robotic-assisted prostate biopsy. Curr Opin Urol. 2012;22:316-319.
16. Valdés Olmos RA, Vidal-Sicart S. SPECT/CT image generation and criteria for sentinel node mapping. In: Mariani G, Manca G, Orsini P, Vidal-Sicart S, Valdes Olmos R, eds. Atlas of Lymphoscintigraphy and Sentinel Node Mapping. Milan, Italy: Springer; 2012:269-283.
17. Vermeeren L, Valdes Olmos RA, Meinhardt W, et al. Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med. 2009;50: 865-870.
18. Vermeeren L, Valdes Olmos RA, Meinhardt W, et al. Intraoperative radioguidance with a portable gamma camera: a novel technique for laparoscopic sentinel node localisation in urological malignancies. Eur J Nucl Med Mol Imaging. 2009;36:1029-1036.
19. Navab N, Blum T, Wang L, Okur A, Wendler T. First deployments of augmented reality in operating rooms. Computer. 2012;45:48-55.
20. Simpfendörfer T, Baumhauer M, Muller M, et al. Augmented reality visualization during laparoscopic radical prostatectomy. J Endourol. 2011;25: 1841-1845.
21. Ukimura O, Nakamoto M, Gill IS. Three-dimensional reconstruction of renovascular-tumor anatomy to facilitate zero-ischemia partial nephrectomy. Eur Urol. 2012;61:211-217.
22. Volonté F, Pugin F, Buchs NC, et al. Console-integrated stereoscopic osirix 3D volume-rendered images for da Vinci colorectal robotic surgery. Surg Innov. May 1, 2012 [Epub ahead of print].
23. Brouwer OR, Buckle T, Bunschoten A, et al. Image navigation as a means to expand the boundaries of fluorescence-guided surgery. Phys Med Biol. 2012; 57:3123-3136.
24. van der Poel HG, Buckle T, Brouwer OR, Valdes Olmos RA, van Leeuwen FW. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol. 2011;60:826-833.
25. Jeschke S, Lusuardi L, Myatt A, Hruby S, Pirich C, Janetschek G. Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging. Urology. 2012;80:1080-1086.